Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2025-12-24 @ 5:21 PM
NCT ID:
NCT00516750
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of invasive bladder cancer
* Must be confirmed by chest and abdominal CT scan OR pelvic MRI scan and transurethral biopsy (with definitive muscle invasion \> T2) within 4 weeks prior to registration
PATIENT CHARACTERISTICS:
* ECOG performance status 0-1
* WBC ≥ 3,000/mm\^3
* Neutrophil count ≥ 1,500/mm\^3
* Platelet count ≥ 100,000/mm\^3
* Total bilirubin ≤ 1.5 mg/dL
* Serum creatinine ≤ 1.5 mg/dL
* AST and ALT ≤ 2.5 x upper limit of normal
* Not pregnant
* No liver cirrhosis
* No ischemic cardiovascular disease or arrhythmia for which treatment is necessary
* No cardiac infarction within the past 6 months
* No interstitial pneumonia, pulmonary fibrosis, or any other diseases by which oxygen inhalation therapy is needed
* No active cancerous lesion other than upper urinary tract tumor
* No high fever or any other infectious symptom
* No uncontrolled hypertension or diabetes mellitus
PRIOR CONCURRENT THERAPY:
* No prior systemic chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT00516750
Study Brief:
Protocol Section:
NCT00516750